Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT01629758
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
* All subjects will have locally advanced or metastatic solid tumors
* For Part 2 (Cohort Expansion):
* Tumor types will be restricted to clear cell renal cell carcinoma (ccRCC), non-small cell lung cancer (NSCLC), and melanoma
* At least 1 lesion with measurable disease
* Only subjects with tumor samples that are PD-L1 positive or negative are eligible
Exclusion Criteria:
* Uncontrolled central nervous system (CNS) or leptomeningeal metastasis
* Inadequate liver or kidney function
* History of autoimmune Disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01629758
Study Brief:
Protocol Section:
NCT01629758